WHO ICTRP trial
A phase I, open-label, randomized, two period, two-way cross over study to…
NL-OMON53489 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON53489 |
|---|---|
| Public title | A phase I, open-label, randomized, two period, two-way cross over study to assess the influence of a high-calorie, high fat meal on the bioavailability of a 40 mg extended release PHA 022121 oral formulation |
| Scientific title | A phase I, open-label, randomized, two period, two-way cross over study to assess the influence of a high-calorie, high fat meal on the bioavailability of a 40 mg extended release PHA 022121 oral formulation - Food effect study on the bioavailability of PHA-022121 formulations |
| Primary sponsor | Pharvaris Netherlands BV |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | angioedema;10018849;10027664;angioedema |
| Interventions | PHA-022121 will be given 1 time per period, so 2 times in total. Each dose that the volunteer will receive is 40 milligrams. ;Bioavailability;Food effect;PHA-022121 |
| Registration date | Mar 7, 2023 |
| Target size | 10 |
| Secondary IDs | 2022-002728-11;NL82642.056.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: